A weekly podcast exploring medicine 4.0 as we launch into the 21st Century of health. Join us as we highlight the science and investment case for the different diseases and conditions that life sciences companies are trying to diagnose and cure.
Publishes | Weekly | Episodes | 16 | Founded | a year ago |
---|---|---|---|---|---|
Categories | Life SciencesScience |
Moderna and BioNTech are getting all of the attention with their phase 3 clinical trials for lung cancer and melanoma. But someone else is already further ahead.
French company Ose Immunotherapeutics has already done a phase 3 study for non small ... more
Cancer vaccines are an area that anyone who is anyone is getting into, but its a field led largely by academics, not-for–profits, and specialist researchers. So this week we go back to basics - science that is.
Australia may not have many cancer va... more
In some ways, cancer vaccines are a history of hype and hope, over success. But that hasnt stopped people from trying. In 2024, biotech CEOs are hoping that this time, its different.
Research houses are predicting significant market growth come 203... more
Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within this. And one says their work is not a vaccine. T... more
People also subscribe to these shows.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #240 | |
Apple Podcasts | #242 | |
Apple Podcasts | #185 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
Gender Skew | |
---|---|
Location | |
Interests | |
Professions | |
Age Range | |
Household Income | |
Social Media Reach |
This podcast focuses on the intersection of medicine, investment, and the emerging capabilities within the life sciences sector. A notable emphasis is placed on innovations in cancer treatments and advanced therapies, particularly in areas like radiopharmaceuticals and kidney disease. Engaging interviews with industry experts, entrepreneurs, and researchers offer insights into new technologies, regulatory landscapes, and investment opportunities that shape the future of healthcare. The discussions reflect a commitment to understanding the complexities of medical advancements while highlighting actionable investment insights for the interested listener.
Rephonic provides a wide range of podcast stats for PHASE3. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to PHASE3 and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for PHASE3, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for PHASE3, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers PHASE3 has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with PHASE3:
1. The Readout Loud
2. Chanticleer
3. Equity Mates Investing Podcast
4. BioCentury This Week
PHASE3 launched a year ago and published 16 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for PHASE3 from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of PHASE3. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on PHASE3 include:
1. Jeannie Jockin
2. Nicolas Poirier
3. Dr. Seth Cheetham
4. Dr. Sharlan Nayak
5. Chris Kallos
6. Stuart Roberts
7. Matt Zeller
8. Dr. Melissa Benson
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.